{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:23:06Z","timestamp":1778034186311,"version":"3.51.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T00:00:00Z","timestamp":1425254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Competence Network Heart Failure"},{"name":"German Ministry of Education and Research","award":["01GL0304, 01GI0205, 01EO1004,"],"award-info":[{"award-number":["01GL0304, 01GI0205, 01EO1004,"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure (HF) pharmacotherapy is often not prescribed according to guidelines. This longitudinal study investigated prescription rates and dosages of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers (ACEi\/ARB), beta-blockers, and mineralocorticoid receptor antagonists (MRA), and concomitant changes of symptoms, echocardiographic parameters of left ventricular (LV) function and morphology and results of the Short Form-36 (SF-36) Health Survey in participants of the Interdisciplinary Network Heart Failure (INH) programme.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The INH study evaluated a nurse-coordinated management, HeartNetCare-HFTM (HNC), against Usual Care (UC) in patients hospitalized for decompensated HF [LV ejection fraction (LVEF) \u226440% before discharge). A total of 706 subjects surviving &amp;gt;18 months (363 UC, 343 HNC) were examined 6-monthly. At baseline, 92% received ACEi\/ARB, (HNC\/UC 91\/93%, P = 0.28), 86% received beta-blockers (86\/86%, P = 0.83), and 44% received MRA (42\/47%, P = 0.07). After 18 months, beta-blocker use had increased only in HNC (+7.6%, P &amp;lt; 0.001). Guideline-recommended target doses were achieved more frequently in HNC for ACEi\/ARB (HNC\/UC: 50\/25%, P &amp;lt; 0.001) and beta-blockers (39\/15%, P &amp;lt; 0.001). The following variables were more improved and\/or better in subjects undergoing HNC compared with UC: LVEF (47 \u00b1 12 vs. 44 \u00b1 12%, P = 0.004, change +17\/+14%, P = 0.010), LV end-diastolic diameter (59 \u00b1 9 vs. 61 \u00b1 9.6 mm, P = 0.024, change \u22122.3\/\u20131.4mm, P = 0.13), New York Heart Association class (1.9 \u00b1 0.7 vs. 2.1 \u00b1 0.7, P = 0.001, change \u22120.44\/\u20130.25, P = 0.002) and SF-36 physical component summary score (41.6 \u00b1 11.2 vs. 38.5 \u00b1 11.8, P = 0.004, change +3.3 vs. +1.1 score points, P &amp;lt; 0.02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Prescription rates and dosages of ACEi\/ARB and beta-blockers improved more in HNC than UC patients. Concomitantly, participation in HNC was associated with significantly better clinical outcomes and more favourable echocardiographic changes after 18 months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.252","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T06:18:49Z","timestamp":1425277129000},"page":"442-452","source":"Crossref","is-referenced-by-count":64,"title":["Nurse-Coordinated Collaborative Disease Management Improves the Quality of Guideline-Recommended Heart Failure Therapy, Patient-Reported Outcomes, and Left Ventricular Remodelling"],"prefix":"10.1093","volume":"17","author":[{"given":"G\u00fclmisal","family":"G\u00fcder","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Cardiology, University Hospital W\u00fcrzburg , Oberd\u00fcrrbacherstr 6, D\u201397080, W\u00fcrzburg ,","place":["Germany"]},{"name":"Comprehensive Heart Failure Center, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"St\u00f6rk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Cardiology, University Hospital W\u00fcrzburg , Oberd\u00fcrrbacherstr 6, D\u201397080, W\u00fcrzburg ,","place":["Germany"]},{"name":"Comprehensive Heart Failure Center, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goetz","family":"Gelbrich","sequence":"additional","affiliation":[{"name":"University of W\u00fcrzburg, Institute of Clinical Epidemiology and Biometry , W\u00fcrzburg ,","place":["Germany"]},{"name":"Clinical Trial Center W\u00fcrzburg, University Hospital W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Brenner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Cardiology, University Hospital W\u00fcrzburg , Oberd\u00fcrrbacherstr 6, D\u201397080, W\u00fcrzburg ,","place":["Germany"]},{"name":"Comprehensive Heart Failure Center, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolas","family":"Deubner","sequence":"additional","affiliation":[{"name":"Comprehensive Heart Failure Center, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]},{"name":"Department of Cardiology, Kerckhoff Klinik , Bad Nauheim ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Morbach","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Cardiology, University Hospital W\u00fcrzburg , Oberd\u00fcrrbacherstr 6, D\u201397080, W\u00fcrzburg ,","place":["Germany"]},{"name":"Comprehensive Heart Failure Center, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Wallenborn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Cardiology, University Hospital W\u00fcrzburg , Oberd\u00fcrrbacherstr 6, D\u201397080, W\u00fcrzburg ,","place":["Germany"]},{"name":"Comprehensive Heart Failure Center, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Berliner","sequence":"additional","affiliation":[{"name":"Comprehensive Heart Failure Center, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]},{"name":"Department of Internal Medicine I, Cardiology, University Hospital Hannover , Hannover ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Ertl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Cardiology, University Hospital W\u00fcrzburg , Oberd\u00fcrrbacherstr 6, D\u201397080, W\u00fcrzburg ,","place":["Germany"]},{"name":"Comprehensive Heart Failure Center, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane E.","family":"Angermann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Cardiology, University Hospital W\u00fcrzburg , Oberd\u00fcrrbacherstr 6, D\u201397080, W\u00fcrzburg ,","place":["Germany"]},{"name":"Comprehensive Heart Failure Center, University of W\u00fcrzburg , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,3,2]]},"reference":[{"key":"2026011921085034700_ejhf252-bib-0001","doi-asserted-by":"crossref","first-page":"e000053","DOI":"10.1161\/JAHA.113.000053","article-title":"Improved survival after heart failure: a community-based perspective","volume":"2","author":"Joffe","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026011921085034700_ejhf252-bib-0002","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N Engl J Med"},{"key":"2026011921085034700_ejhf252-bib-0003","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"2026011921085034700_ejhf252-bib-0004","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"2026011921085034700_ejhf252-bib-0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ejheart.2007.09.003","article-title":"Comparison of the beneficial effect of beta-blockers on mortality in patients with ischaemic or non-ischaemic systolic heart failure: a meta-analysis of randomised controlled trials","volume":"9","author":"Fauchier","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0006","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/eurjhf\/hfr093","article-title":"CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure","volume":"13","author":"McMurray","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0007","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"2026011921085034700_ejhf252-bib-0008","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"key":"2026011921085034700_ejhf252-bib-0009","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0010","first-page":"e240","article-title":"2013 ACCF\/AHA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"2026011921085034700_ejhf252-bib-0011","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.ijcard.2012.12.069","article-title":"Mismatch between heart failure patients in clinical trials and the real world","volume":"168","author":"Niederseer","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026011921085034700_ejhf252-bib-0012","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.ejheart.2008.09.008","article-title":"Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study","volume":"10","author":"Stork","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0013","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2008.09.031","article-title":"Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry","volume":"53","author":"Hernandez","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011921085034700_ejhf252-bib-0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1751-7133.2011.00250.x","article-title":"Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF","volume":"18","author":"Gheorghiade","year":"2012","journal-title":"Congest Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2004.03.004","article-title":"Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design","volume":"148","author":"Fonarow","year":"2004","journal-title":"Am Heart J"},{"key":"2026011921085034700_ejhf252-bib-0016","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/eurjhf\/hfs159","article-title":"The benefits of using a heart failure management programme in Swedish primary healthcare","volume":"15","author":"Agvall","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.111.962969","article-title":"Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study","volume":"5","author":"Angermann","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0018","first-page":"1086","article-title":"American Society of Echocardiography recommendations for use of echocardiography in clinical trials","volume":"17","author":"Gottdiener","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"2026011921085034700_ejhf252-bib-0019","volume-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","author":"Ware","year":"1996","edition":"2nd edn."},{"key":"2026011921085034700_ejhf252-bib-0020","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0277-9536(95)00115-N","article-title":"German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment","volume":"41","author":"Bullinger","year":"1995","journal-title":"Soc Sci Med"},{"key":"2026011921085034700_ejhf252-bib-0021","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0895-4356(98)00107-3","article-title":"The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment","volume":"51","author":"Ware","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2026011921085034700_ejhf252-bib-0022","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0023","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/01.CIR.0000070952.08969.5B","article-title":"Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure","volume":"107","author":"Ansari","year":"2003","journal-title":"Circulation"},{"key":"2026011921085034700_ejhf252-bib-0024","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.ijcard.2013.05.090","article-title":"Effectiveness of a multidimensional home nurse led heart failure disease management program \u2013 a French nationwide time-series comparison","volume":"168","author":"Agrinier","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026011921085034700_ejhf252-bib-0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2014.04.255","article-title":"Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure","volume":"175","author":"Poelzl","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026011921085034700_ejhf252-bib-0026","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/eurjhf\/hfq169","article-title":"Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure \u2013SIGNAL-HF (Swedish Intervention study \u2013 Guidelines and NT-proBNP AnaLysis in Heart Failure)","volume":"12","author":"Persson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0027","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardfail.2010.10.010","article-title":"Nurse-led titration of beta-adrenoreceptor blocking agents in chronic heart failure patients in the community","volume":"17","author":"Driscoll","year":"2011","journal-title":"J Card Fail"},{"key":"2026011921085034700_ejhf252-bib-0028","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCULATIONAHA.110.989632","article-title":"Associations between outpatient heart failure process-of-care measures and mortality","volume":"123","author":"Fonarow","year":"2011","journal-title":"Circulation"},{"key":"2026011921085034700_ejhf252-bib-0029","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"2026011921085034700_ejhf252-bib-0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.CIR.86.2.431","article-title":"Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure","volume":"86","author":"Konstam","year":"1992","journal-title":"Circulation"},{"key":"2026011921085034700_ejhf252-bib-0031","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.91.10.2573","article-title":"Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy","volume":"91","author":"Greenberg","year":"1995","journal-title":"Circulation"},{"key":"2026011921085034700_ejhf252-bib-0032","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0735-1097(97)00012-0","article-title":"Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease","volume":"29","author":"Doughty","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026011921085034700_ejhf252-bib-0033","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCHEARTFAILURE.113.000929","article-title":"Predictors of spontaneous reverse remodeling in mild heart failure patients with left ventricular dysfunction","volume":"7","author":"Brenyo","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0034","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jacc.2010.11.030","article-title":"Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment","volume":"57","author":"Merlo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026011921085034700_ejhf252-bib-0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00392-012-0531-4","article-title":"Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression","volume":"102","author":"Schowalter","year":"2013","journal-title":"Clin Res Cardiol."},{"key":"2026011921085034700_ejhf252-bib-0036","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijcard.2007.01.044","article-title":"The enigma of quality of life in patients with heart failure","volume":"125","author":"Dobre","year":"2008","journal-title":"Int J Cardiol."},{"key":"2026011921085034700_ejhf252-bib-0037","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0735-1097(00)01006-8","article-title":"Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure","volume":"36","author":"Groenning","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026011921085034700_ejhf252-bib-0038","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/CIRCHEARTFAILURE.108.825059","article-title":"Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors","volume":"2","author":"Guder","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2026011921085034700_ejhf252-bib-0039","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jacc.2006.11.042","article-title":"Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction","volume":"49","author":"Goldenberg","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026011921085034700_ejhf252-bib-0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.252","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/4\/442\/66423597\/eurjhf_17_4_442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/4\/442\/66423597\/eurjhf_17_4_442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:09:13Z","timestamp":1768874953000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/17\/4\/442\/8426613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,2]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,3,2]]},"published-print":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.252","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,4]]},"published":{"date-parts":[[2015,3,2]]}}}